MyBlueDotsNewron and Myung In Pharm Announce License Agreement for evenamide in South Korea MyBlueDots8 months ago01 mins MILAN, Italy & MORRISTOWN, New Jersey & SEOUL, Republic of Korea–(BUSINESS WIRE)—- $NWRN #schizophrenia–Newron and Myung In Pharm, South Korea’s leading specialist CNS pharma company, announce license agreement for evenamide in South Korea. Post navigation Previous: Henry Schein Opens Customer Emergency Support Hotline in Response to California FiresNext: What Illinois residents should know, following the first US death from bird virus